Karl Zilles Selected Research

Neurotransmitter Receptors (Neurotransmitter Receptor)

1/2022	Personalized brain models identify neurotransmitter receptor changes in Alzheimer's disease.
4/2020	Multimodal mapping and analysis of the cyto- and receptorarchitecture of the human hippocampus.
8/2013	Neurotransmitter receptor alterations in hepatic encephalopathy: a review.
8/2010	Inhibition of glutamate/glutamine cycle in vivo results in decreased benzodiazepine binding and differentially regulated GABAergic subunit expression in the rat brain.
1/2009	Neurotransmitter receptor imbalances in motor cortex and basal ganglia in hepatic encephalopathy.
8/2005	Regional and subtype selective changes of neurotransmitter receptor density in a rat transgenic for the Huntington's disease mutation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karl Zilles Research Topics

Disease

6	Hepatic Encephalopathy 08/2013 - 05/2002
6	Glioma (Gliomas) 05/2013 - 07/2003
5	Neoplasms (Cancer) 05/2013 - 07/2003
2	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 02/2018
2	Parkinson Disease (Parkinson's Disease) 01/2018 - 01/2018
2	Infarction (Infarctions) 05/2013 - 03/2006
2	Epilepsy (Aura) 08/2010 - 10/2008
2	Fibrosis (Cirrhosis) 07/2010 - 03/2008
2	Seizures (Absence Seizure) 10/2008 - 07/2005
2	Liver Cirrhosis (Hepatic Cirrhosis) 03/2008 - 10/2006
2	Schizophrenia (Dementia Praecox) 01/2008 - 12/2005
2	Stroke (Strokes) 03/2006 - 01/2003
1	Clinical Deterioration 01/2022
1	Shock 04/2020
1	Temporal Lobe Epilepsy 10/2018
1	Dementia (Dementias) 07/2015
1	Partial Epilepsies (Epilepsy, Partial) 11/2012
1	Mood Disorders (Mood Disorder) 03/2012
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 06/2009
1	Lipoid Proteinosis of Urbach and Wiethe (Lipoidproteinosis) 03/2009
1	Motor Disorders 04/2008
1	Glioblastoma (Glioblastoma Multiforme) 01/2008
1	Sleep Deprivation 02/2007
1	Brain Ischemia (Cerebral Ischemia) 03/2006
1	Prodromal Symptoms 12/2005
1	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2005
1	Huntington Disease (Huntington's Disease) 08/2005
1	Ischemia 12/2004
1	Body Weight (Weight, Body) 12/2004
1	Gliosis 12/2004

Drug/Important Bio-Agent (IBA)

6	Neurotransmitter Receptors (Neurotransmitter Receptor)IBA 01/2022 - 08/2005
4	Tyrosine (L-Tyrosine)FDA Link 07/2010 - 07/2003
4	Purinergic P1 Receptors (Adenosine Receptor)IBA 03/2008 - 03/2005
3	Pentylenetetrazole (Metrazol)IBA 08/2010 - 07/2005
3	Neurotransmitter Agents (Neurotransmitter)IBA 06/2009 - 03/2008
3	Indicators and Reagents (Reagents)IBA 01/2008 - 03/2005
2	Biological ProductsIBA 01/2022 - 01/2008
2	Cholinergic Agents (Cholinergics)IBA 01/2018 - 08/2005
2	altanserinIBA 03/2009 - 12/2005
2	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 03/2009 - 12/2005
1	Amyloid (Amyloid Fibrils)IBA 01/2022
1	Cholinergic ReceptorsIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	N-Ethylmaleimide-Sensitive Proteins (N-Ethylmaleimide-Sensitive Fusion Protein)IBA 10/2018
1	Staphylococcal Protein A (Protein A)IBA 10/2018
1	Type A Botulinum Toxins (Botox)FDA Link 01/2018
1	incobotulinumtoxinA FDA Link 01/2018
1	Proline (L-Proline)FDA Link 05/2013
1	LigandsIBA 11/2012
1	Messenger RNA (mRNA)IBA 11/2010
1	RNA (Ribonucleic Acid)IBA 07/2010
1	8-hydroxyguanosineIBA 07/2010
1	Proteins (Proteins, Gene)FDA Link 07/2010
1	Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA 10/2008
1	ElementsIBA 01/2008
1	CopperIBA 01/2008
1	ZincIBA 01/2008
1	8- cyclopenta- 3- (3- fluoropropyl)- 1- propylxanthineIBA 02/2007
1	Fluvoxamine (Luvox)FDA LinkGeneric 10/2006
1	CytochromesIBA 10/2006
1	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 10/2006
1	Antidepressive Agents (Antidepressants)IBA 10/2006
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 03/2006
1	SolventsIBA 03/2006
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 03/2006
1	Antipsychotic Agents (Antipsychotics)IBA 12/2005
1	Huntingtin ProteinIBA 08/2005
1	polyglutamineIBA 08/2005
1	Adenosine (Adenocard)FDA LinkGeneric 03/2005
1	Heme Oxygenase-1IBA 12/2004
1	Glial Fibrillary Acidic ProteinIBA 12/2004
1	ManganeseIBA 11/2003
1	Methionine (L-Methionine)FDA Link 07/2003
1	gamma-Aminobutyric Acid (GABA)IBA 01/2003
1	Butyric Acid (Butanoic Acid)IBA 01/2003
1	AmmoniaIBA 05/2002

Therapy/Procedure

2	Deep Brain Stimulation 02/2018 - 07/2015
1	Therapeutics 03/2012
1	Laser Therapy (Surgery, Laser) 01/2008